Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.055 USD | +1.83% | -1.29% | -4.66% |
May. 14 | Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 | MT |
May. 14 | Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 2.07M | Sales 2025 * | 54.11M | Capitalization | 213M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -22M | EV / Sales 2024 * | 103 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.93 x |
P/E ratio 2024 * |
-3.49
x | P/E ratio 2025 * |
-10.6
x | Employees | 40 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.13% |
Latest transcript on Ovid Therapeutics Inc.
1 day | -0.33% | ||
1 week | -4.46% | ||
Current month | -1.64% | ||
1 month | -3.23% | ||
3 months | -17.36% | ||
6 months | -7.12% | ||
Current year | -6.83% |
Managers | Title | Age | Since |
---|---|---|---|
Jeremy Levin
CEO | Chief Executive Officer | 70 | 14-03-31 |
Jeffrey Rona
DFI | Director of Finance/CFO | 55 | 18-12-31 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 59 | 17-06-13 |
Bart Friedman
BRD | Director/Board Member | 79 | 15-11-22 |
Jeremy Levin
CEO | Chief Executive Officer | 70 | 14-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 3.06 | +2.00% | 79 555 |
24-05-24 | 3 | -0.33% | 113,606 |
24-05-23 | 3.01 | -6.81% | 133,120 |
24-05-22 | 3.23 | +3.86% | 117,264 |
24-05-21 | 3.11 | -0.96% | 41,552 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.83% | 213M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.48% | 22.1B | |
-9.28% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- OVID Stock